Navigation Links
US Senate Passes Stem Cell Research Bill

The US Senate has passed a bill that aims to loosen President George Bush's restrictions on human embryonic stem cell research for the second time// in nine months, but has once again fallen short of the 67 votes needed to override a promised veto, media reports said.

The Senate voted 63 to 34 to pass the Stem Cell Research Enhancement Act, which would allow federally funded studies of stem cells isolated from embryos slated for destruction at fertility clinics, the Washington Post reported Wednesday.

The vote capped 20 hours of often passionate debate, with proponents focusing on the cells' potential to help treat a wide range of diseases and opponents decrying the fact that human embryos must be destroyed to retrieve them.

With the House having passed a similar bill in January, the two chambers are now set to hammer out compromise wording and send the legislation to Bush. But the White House Tuesday set the stage for a new Bush veto, saying it was unthinkable that public tax money should be used to destroy human embryos.

Bush used his power of veto for the first time in his presidency to slap down a similar text passed in Congress last year, when it was then controlled by his Republican party.

However, proponents are relishing the fact that they will have the opportunity to rebuke the president by overriding that veto this time.

Although the House majority favouring the legislation is 15 votes larger this year than that in 2005, it is still dozens short of the two-thirds needed for an override.

In that case, Bush's veto pen will prevail and the situation will revert to what it has been since Aug 9, 2001 -- when Bush, in his first major televised address to the nation, declared that federal funds could only be used to study stem cells derived from embryos already destroyed by that date.

Source-IANS/B
'"/>




Page: 1

Related medicine news :

1. Senate assures ban on smoking
2. US Senate Votes against Testing of Pesticide on Humans
3. US Senate Approves Embryo-research Plan Despite Presidents Refusal
4. Senate Committee Approves Telemedicine Mental Health Bill
5. Organ Donation Crusader Passes Away
6. A Mother Passes On A Rare, Terminal Brain Disease To Her Three Children
7. Renowned Doctor Passes Away
8. Founder of Enron, Ken Lay Passes Away
9. Maoist Leader-Turned Social Activist Passes Away
10. Jeff Getty, AIDS Activist, Passes Away
11. WHO Passes Rotavirus Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: